Efficacy and safety of eculizumab in Guillain-Barré syndrome: a meta-analysis of randomized controlled trials
Background: Guillain-Barré syndrome (GBS) is an acute, immune-mediated disorder of the peripheral nervous system, often leading to significant morbidity and, in severe cases, mortality. Despite the availability of treatments such as intravenous immunoglobulin and plasma exchange, a substantial proportion of patients ex...